181 related articles for article (PubMed ID: 16008743)
1. The optimal timing of liver transplantation in patients with chronic cholestatic liver disease.
Rave S; Schalm SW;
Transpl Int; 2005 Aug; 18(8):937-40. PubMed ID: 16008743
[TBL] [Abstract][Full Text] [Related]
2. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?
Hay JE
Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S9-17. PubMed ID: 9742489
[TBL] [Abstract][Full Text] [Related]
3. Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis.
Wiesner RH; Porayko MK; Dickson ER; Gores GJ; LaRusso NF; Hay JE; Wahlstrom HE; Krom RA
Hepatology; 1992 Nov; 16(5):1290-9. PubMed ID: 1427667
[TBL] [Abstract][Full Text] [Related]
4. Midterm cost-effectiveness of the liver transplantation program of England and Wales for three disease groups.
Longworth L; Young T; Buxton MJ; Ratcliffe J; Neuberger J; Burroughs A; Bryan S;
Liver Transpl; 2003 Dec; 9(12):1295-307. PubMed ID: 14625830
[TBL] [Abstract][Full Text] [Related]
5. Liver transplantation for primary sclerosing cholangitis in the Nordic countries: outcome after acceptance to the waiting list.
Brandsaeter B; Broomé U; Isoniemi H; Friman S; Hansen B; Schrumpf E; Oksanen A; Ericzon BG; Höckerstedt K; Mäkisalo H; Olsson R; Olausson M; Kirkegaard P; Bjøro K
Liver Transpl; 2003 Sep; 9(9):961-9. PubMed ID: 12942458
[TBL] [Abstract][Full Text] [Related]
6. Liver transplantation for cholestatic liver disease: screening and assessment of risk factors.
Crippin JS
Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S2-8. PubMed ID: 9742488
[TBL] [Abstract][Full Text] [Related]
7. Biliary malignancies in primary sclerosing cholangitis: timing for liver transplantation.
Nashan B; Schlitt HJ; Tusch G; Oldhafer KJ; Ringe B; Wagner S; Pichlmayr R
Hepatology; 1996 May; 23(5):1105-11. PubMed ID: 8621141
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of liver transplantation in patients with PSC: a comparative analysis with PBC.
Maheshwari A; Yoo HY; Thuluvath PJ
Am J Gastroenterol; 2004 Mar; 99(3):538-42. PubMed ID: 15056099
[TBL] [Abstract][Full Text] [Related]
9. [Liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis].
Díliz Pérez HS
Rev Gastroenterol Mex; 1995; 60(4 Suppl 2):S81-3. PubMed ID: 8948792
[No Abstract] [Full Text] [Related]
10. Primary sclerosing cholangitis: the emerging role for liver transplantation.
Langnas AN; Grazi GL; Stratta RJ; Wood RP; Marujo W; Markin RS; Donovan J; Burnett D; Zetterman R; Sorrell M
Am J Gastroenterol; 1990 Sep; 85(9):1136-41. PubMed ID: 2167607
[TBL] [Abstract][Full Text] [Related]
11. Orthotopic liver transplantation for cholestatic diseases.
Patkowski W; Skalski M; Zieniewicz K; Nyckowski P; Smoter P; Krawczyk M
Hepatogastroenterology; 2010; 57(99-100):605-10. PubMed ID: 20698235
[TBL] [Abstract][Full Text] [Related]
12. Quality of life before and after liver transplantation for cholestatic liver disease.
Gross CR; Malinchoc M; Kim WR; Evans RW; Wiesner RH; Petz JL; Crippin JS; Klintmalm GB; Levy MF; Ricci P; Therneau TM; Dickson ER
Hepatology; 1999 Feb; 29(2):356-64. PubMed ID: 9918910
[TBL] [Abstract][Full Text] [Related]
13. Preoperative evaluation, preparation, and timing of orthotopic liver transplantation in the adult.
Donovan JP; Zetterman RK; Burnett DA; Sorrell MF
Semin Liver Dis; 1989 Aug; 9(3):168-75. PubMed ID: 2683102
[TBL] [Abstract][Full Text] [Related]
14. [Recurrence of chronic cholestatic liver diseases following liver transplantation].
Cirera I
Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():77-80. PubMed ID: 11968350
[No Abstract] [Full Text] [Related]
15. [Indications and results of liver transplantation in cholestatic diseases].
de la Mata M; Montero JL; Fraga E; Delgado M; Costán G; Padillo J; Díaz C; Rufián S; López-Cillero P; Solórzano G; Pera C; Miño G
Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():39-42. PubMed ID: 11968341
[No Abstract] [Full Text] [Related]
16. Late acute rejection after liver transplantation impacts patient survival.
Uemura T; Ikegami T; Sanchez EQ; Jennings LW; Narasimhan G; McKenna GJ; Randall HB; Chinnakotla S; Levy MF; Goldstein RM; Klintmalm GB
Clin Transplant; 2008; 22(3):316-23. PubMed ID: 18190550
[TBL] [Abstract][Full Text] [Related]
17. Bone disease in liver transplant recipients: incidence, timing, and risk factors.
Porayko MK; Wiesner RH; Hay JE; Krom RA; Dickson ER; Beaver S; Schwerman L
Transplant Proc; 1991 Feb; 23(1 Pt 2):1462-5. PubMed ID: 1989266
[No Abstract] [Full Text] [Related]
18. Optimal timing of liver transplantation for primary biliary cirrhosis.
Kim WR; Wiesner RH; Therneau TM; Poterucha JJ; Porayko MK; Evans RW; Klintmalm GB; Crippin JS; Krom RA; Dickson ER
Hepatology; 1998 Jul; 28(1):33-8. PubMed ID: 9657093
[TBL] [Abstract][Full Text] [Related]
19. Poor outcome in progressive sclerosing cholangitis after septic shock.
Kulaksiz H; Heuberger D; Engler S; Stiehl A
Endoscopy; 2008 Mar; 40(3):214-8. PubMed ID: 18264887
[TBL] [Abstract][Full Text] [Related]
20. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: predicting outcomes with natural history models.
Wiesner RH
Mayo Clin Proc; 1998 Jun; 73(6):575-88. PubMed ID: 9621867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
